Skip to content

Study on the safety and efficacy of es ketamine in cesarean section under general anesthesia

Study on the safety and efficacy of es ketamine in cesarean section under general anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055208
Enrollment
Unknown
Registered
2022-01-03
Start date
2022-01-03
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Affiliated Hospital of Weifang Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
23 Years to 43 Years

Inclusion criteria

Inclusion criteria: 1. Aged 23-43 years, gestational age is 37-42 weeks; 2. Expectant mothers undergoing cesarean section; 3. ASA score is I-II; 4. The subject weighs 65-95kg, including the boundary value; 5. Have a detailed understanding of the nature, significance, possible benefits, potential risks and discomfort of the trial before the trial, and voluntarily participate in this clinical trial, able to communicate well with investigators, and comply with the requirements of the entire study, and signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to general anesthesia; 2. Those who are allergic to ketamine hydrochloride, esketamine hydrochloride, propofol, opioids, tropisetron hydrochloride, and neostigmine; 3. The mother has neuropsychiatric disorders or insufficiency of heart, lung, liver and kidney functions; 4. The fetus has intrauterine distress; 5. Patients with a history of mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.), history of drugs and cognitive dysfunction; 6. Those who have participated in other drug trials 3 months before enrollment; 7. Other investigators deem it unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Blood pressure;Blood oxygen saturation;Heart rate;Apgar score;

Countries

China

Contacts

Public ContactWang Dewei

Affiliated Hospital of Weifang Medical College

wangdw2276@sina.com+86 13863652276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026